These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 21665906

  • 1. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
    Hocquet D, Colomb M, Dehecq B, Belmonte O, Courvalin P, Plésiat P, Meziane-Cherif D.
    J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
    [Abstract] [Full Text] [Related]

  • 2. Structural insights into the loss of penicillinase and the gain of ceftazidimase activities by OXA-145 β-lactamase in Pseudomonas aeruginosa.
    Meziane-Cherif D, Bonnet R, Haouz A, Courvalin P.
    J Antimicrob Chemother; 2016 Feb; 71(2):395-402. PubMed ID: 26568564
    [Abstract] [Full Text] [Related]

  • 3. Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location.
    Pellegrini C, Mercuri PS, Celenza G, Galleni M, Segatore B, Sacchetti E, Volpe R, Amicosante G, Perilli M.
    J Antimicrob Chemother; 2009 May; 63(5):901-8. PubMed ID: 19270313
    [Abstract] [Full Text] [Related]

  • 4. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa.
    Girlich D, Naas T, Nordmann P.
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2043-8. PubMed ID: 15155197
    [Abstract] [Full Text] [Related]

  • 5. Purification and characterization of a new β-lactamase OXA-205 from Pseudomonas aeruginosa.
    Krasauskas R, Labeikytė D, Markuckas A, Povilonis J, Armalytė J, Plančiūnienė R, Kavaliauskas P, Sužiedėlienė E.
    Ann Clin Microbiol Antimicrob; 2015 Nov 26; 14():52. PubMed ID: 26611758
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea.
    Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, Kang MW.
    J Antimicrob Chemother; 2005 Jul 26; 56(1):122-7. PubMed ID: 15890715
    [Abstract] [Full Text] [Related]

  • 7. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
    Bae IK, Lee BH, Hwang HY, Jeong SH, Hong SG, Chang CL, Kwak HS, Kim HJ, Youn H.
    J Antimicrob Chemother; 2006 Aug 26; 58(2):315-9. PubMed ID: 16785225
    [Abstract] [Full Text] [Related]

  • 8. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Bae IK, Lee YN, Hwang HY, Jeong SH, Lee SJ, Kwak HS, Song W, Kim HJ, Youn H.
    J Antimicrob Chemother; 2006 Dec 26; 58(6):1257-9. PubMed ID: 17003059
    [Abstract] [Full Text] [Related]

  • 9. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
    Yan JJ, Hsueh PR, Lu JJ, Chang FY, Ko WC, Wu JJ.
    J Antimicrob Chemother; 2006 Sep 26; 58(3):530-6. PubMed ID: 16816399
    [Abstract] [Full Text] [Related]

  • 10. Identification of blaOXA-128 and blaOXA-129, two novel OXA-type extended-spectrum-β-lactamases in Pseudomonas aeruginosa, in Hunan Province, China.
    Liu W, Liu X, Liao J, Zhang Y, Liang X.
    J Basic Microbiol; 2010 Dec 26; 50 Suppl 1():S116-9. PubMed ID: 20967789
    [Abstract] [Full Text] [Related]

  • 11. Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
    Arca-Suárez J, Fraile-Ribot P, Vázquez-Ucha JC, Cabot G, Martínez-Guitián M, Lence E, González-Bello C, Beceiro A, Rodríguez-Iglesias M, Galán-Sánchez F, Bou G, Oliver A.
    Antimicrob Agents Chemother; 2019 Oct 26; 63(10):. PubMed ID: 31383659
    [Abstract] [Full Text] [Related]

  • 12. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
    Yan JJ, Tsai SH, Chuang CL, Wu JJ.
    J Microbiol Immunol Infect; 2006 Apr 26; 39(2):130-4. PubMed ID: 16604245
    [Abstract] [Full Text] [Related]

  • 13. OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate.
    Giuliani F, Docquier JD, Riccio ML, Pagani L, Rossolini GM.
    Antimicrob Agents Chemother; 2005 May 26; 49(5):1973-80. PubMed ID: 15855521
    [Abstract] [Full Text] [Related]

  • 14. Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.
    Rodríguez-Martínez JM, Fernández-Echauri P, Fernández-Cuenca F, Diaz de Alba P, Briales A, Pascual A.
    J Antimicrob Chemother; 2012 Jan 26; 67(1):64-8. PubMed ID: 22001269
    [Abstract] [Full Text] [Related]

  • 15. [Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient].
    Aktaş Z, Gönüllü N, Schneider I, Bal C, Bauernfeind A.
    Mikrobiyol Bul; 2005 Oct 26; 39(4):421-9. PubMed ID: 16544543
    [Abstract] [Full Text] [Related]

  • 16. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H, Poirel L, Nordmann P.
    J Antimicrob Chemother; 2007 Sep 26; 60(3):490-4. PubMed ID: 17586561
    [Abstract] [Full Text] [Related]

  • 17. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.
    Danel F, Hall LM, Gur D, Livermore DM.
    Antimicrob Agents Chemother; 1997 Apr 26; 41(4):785-90. PubMed ID: 9087490
    [Abstract] [Full Text] [Related]

  • 18. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E, Kühn A, Mack D, Laufs R.
    J Antimicrob Chemother; 2004 Aug 26; 54(2):406-9. PubMed ID: 15201232
    [Abstract] [Full Text] [Related]

  • 19. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
    Kimura S, Ishii Y, Tateda K, Yamaguchi K.
    Int J Antimicrob Agents; 2007 Mar 26; 29(3):326-31. PubMed ID: 17258896
    [Abstract] [Full Text] [Related]

  • 20. Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum.
    Voha C, Docquier JD, Rossolini GM, Fosse T.
    Antimicrob Agents Chemother; 2006 Aug 26; 50(8):2673-9. PubMed ID: 16870757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.